JP2002513802A5 - - Google Patents

Download PDF

Info

Publication number
JP2002513802A5
JP2002513802A5 JP2000547111A JP2000547111A JP2002513802A5 JP 2002513802 A5 JP2002513802 A5 JP 2002513802A5 JP 2000547111 A JP2000547111 A JP 2000547111A JP 2000547111 A JP2000547111 A JP 2000547111A JP 2002513802 A5 JP2002513802 A5 JP 2002513802A5
Authority
JP
Japan
Prior art keywords
peptide
residues
strain
seq
terminal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000547111A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002513802A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CA1999/000366 external-priority patent/WO1999057142A2/en
Publication of JP2002513802A publication Critical patent/JP2002513802A/ja
Publication of JP2002513802A5 publication Critical patent/JP2002513802A5/ja
Pending legal-status Critical Current

Links

JP2000547111A 1998-05-06 1999-05-06 Pseudomonasaeruginosaのためのワクチン Pending JP2002513802A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US8444498P 1998-05-06 1998-05-06
US60/084,444 1998-05-06
PCT/CA1999/000366 WO1999057142A2 (en) 1998-05-06 1999-05-06 Vaccine for $i(pseudomonas aeruginosa)

Publications (2)

Publication Number Publication Date
JP2002513802A JP2002513802A (ja) 2002-05-14
JP2002513802A5 true JP2002513802A5 (enExample) 2006-06-29

Family

ID=22185008

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000547111A Pending JP2002513802A (ja) 1998-05-06 1999-05-06 Pseudomonasaeruginosaのためのワクチン

Country Status (6)

Country Link
US (2) US6541007B1 (enExample)
EP (1) EP1082342A2 (enExample)
JP (1) JP2002513802A (enExample)
AU (1) AU758235B2 (enExample)
CA (1) CA2328495A1 (enExample)
WO (1) WO1999057142A2 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999057142A2 (en) * 1998-05-06 1999-11-11 The Governors Of The University Of Alberta Vaccine for $i(pseudomonas aeruginosa)
US20030228324A1 (en) * 1999-05-06 2003-12-11 Malcolm Andrew J. Peptide compositions and methods of producing and using same
WO2002060935A2 (en) * 2000-12-21 2002-08-08 The Government Of The United States As Represented By The Secretary Of The Department Of Health And Human Services A chimeric protein comprising non-toxic pseudomonas exotoxin a and type iv pilin sequences
WO2003042240A2 (en) * 2001-11-13 2003-05-22 Shire Biochem Inc. Polypeptides of pseudomonas aeruginosa
EP1790659B1 (en) 2001-11-13 2013-07-31 ID Biomedical Corporation Polypeptides of pseudomonas aeruginosa
US20090208535A1 (en) * 2004-06-28 2009-08-20 Proteome Systems Intellectual Property Pty Ltd Novel Methods of Diagnosis of Treatment of P. Aeruginosa Infection and Reagents Therefor
AU2005294436A1 (en) 2004-10-04 2006-04-20 Trinity Biosystems, Inc. Methods and compositions for immunizing against Pseudomonas infection
US7976851B2 (en) * 2005-07-22 2011-07-12 The Regents Of The University Of Colorado, A Body Corporate Non-toxic biofilm inhibitor
WO2007093177A2 (en) 2006-02-14 2007-08-23 Vladimir Berezin Metallothionein-derived peptide fragments
RU2553557C2 (ru) * 2013-07-08 2015-06-20 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Кубанский государственный аграрный университет" Способ изготовления вакцины, ассоциированной против псевдомоноза и вирусной геморрагической болезни кроликов
EP3122900A1 (en) 2014-03-24 2017-02-01 F. Hoffmann-La Roche AG Cancer treatment with c-met antagonists and correlation of the latter with hgf expression

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6075181A (en) * 1990-01-12 2000-06-13 Abgenix, Inc. Human antibodies derived from immunized xenomice
US6150584A (en) * 1990-01-12 2000-11-21 Abgenix, Inc. Human antibodies derived from immunized xenomice
US5223604A (en) * 1991-06-25 1993-06-29 S.P.I. Synthetic Peptides Incorporated Pseudomonas exoenzyme s peptide composition and method
WO1999057142A2 (en) * 1998-05-06 1999-11-11 The Governors Of The University Of Alberta Vaccine for $i(pseudomonas aeruginosa)

Similar Documents

Publication Publication Date Title
CA2149319C (en) Haemophilus outer membrane protein
US20030021795A1 (en) Use of coiled-coil structural scaffold to generate structure-specific peptides
CA1340530C (en) Synthetic pseudomonas aeruginosa pilin peptide and related vaccines and diagnostics
SK151198A3 (en) Pathogenic microorganism b.burgdorferi and method for its isolation and recultivation
JP2004518624A5 (enExample)
SK168497A3 (en) Streptococcal heat shock proteins members of the hsp70 family
JP2002513802A5 (enExample)
JPH07126291A (ja) 肺炎球菌表面プロテインaのエピトープ領域
CA2257826C (en) Helicobacter pylori adhesin binding group antigen
JP5661744B2 (ja) 腸球菌由来のポリペプチド、及びワクチン接種のためのその使用
JP2002511847A (ja) Porphyromonas gingivalisに関連した歯周病の診断および治療のための合成ペプチド構築物
WO2006041906A3 (en) Methods and compositions for immunizing against pseudomonas infection
Batista et al. Immunogenicity and in vitro and in vivo protective effects of antibodies targeting a recombinant form of the Streptococcus mutans P1 surface protein
Woollard et al. Synthetic peptides induce antibody against a host-protective antigen of Echinococcus granulosus
AU661465B2 (en) Pseudomonas peptide composition and method for producing the same
AU702637B2 (en) Hybrid molecules between heat-labile enterotoxin and cholera toxin B subunits
WO1999057142A3 (en) Vaccine for $i(pseudomonas aeruginosa)
US4584195A (en) Broad spectrum vaccine against gonorrhea
Panezutti et al. Identification of surface-exposed B-cell epitopes recognized by Haemophilus influenzae type b P1-specific monoclonal antibodies
US4622223A (en) Broad spectrum vaccine against gonorrhea
WO1994008013A9 (en) Pilin variants and uses thereof
Olson et al. Identification of functional epitopes of Pseudomonas aeruginosa exotoxin A using synthetic peptides and subclone products
WO1994008013A1 (en) Pilin variants and uses thereof
SK180798A3 (en) A vaccine composition comprising helicobacter pylori flagellin polypeptide
Raupach et al. Elucidation of linear epitopes of pertussis toxin using overlapping synthetic decapeptides: identification of a human B-cell determinant in the S1 subunit indicative of acute infections